Bank of America’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.6M Buy
554,621
+54,656
+11% +$4.48M ﹤0.01% 1732
2025
Q4
$39M Buy
499,965
+182,765
+58% +$14.8M ﹤0.01% 1730
2025
Q3
$26.9M Buy
317,200
+138,194
+77% +$11.1M ﹤0.01% 2321
2025
Q2
$14M Buy
179,006
+7,438
+4% +$548K ﹤0.01% 2905
2025
Q1
$12.4M Buy
171,568
+20,326
+13% +$1.71M ﹤0.01% 2922
2024
Q4
$13.4M Sell
151,242
-5,369
-3% -$478K ﹤0.01% 2657
2024
Q3
$13.3M Buy
156,611
+5,956
+4% +$528K ﹤0.01% 2799
2024
Q2
$13.9M Buy
150,655
+12,761
+9% +$1.29M ﹤0.01% 2607
2024
Q1
$15.6M Buy
137,894
+11,675
+9% +$1.17M ﹤0.01% 2523
2023
Q4
$11.8M Buy
126,219
+7,660
+6% +$674K ﹤0.01% 2707
2023
Q3
$10.9M Buy
118,559
+955
+0.8% +$103K ﹤0.01% 2635
2023
Q2
$14.3M Buy
117,604
+21,551
+22% +$2.32M ﹤0.01% 2346
2023
Q1
$9.4M Buy
96,053
+1,482
+2% +$141K ﹤0.01% 2887
2022
Q4
$7.66M Sell
94,571
-4,412
-4% -$370K ﹤0.01% 2949
2022
Q3
$7.52M Sell
98,983
-19,191
-16% -$1.85M ﹤0.01% 2906
2022
Q2
$12.9M Buy
118,174
+38,264
+48% +$4.06M ﹤0.01% 2424
2022
Q1
$7.95M Buy
79,910
+18,446
+30% +$1.76M ﹤0.01% 3089
2021
Q4
$5.87M Buy
61,464
+2,518
+4% +$252K ﹤0.01% 3490
2021
Q3
$6.52M Buy
58,946
+8,564
+17% +$976K ﹤0.01% 3297
2021
Q2
$5.84M Sell
50,382
-21,406
-30% -$2.46M ﹤0.01% 3378
2021
Q1
$7.47M Buy
71,788
+5,330
+8% +$663K ﹤0.01% 3002
2020
Q4
$7.99M Buy
66,458
+7,256
+12% +$732K ﹤0.01% 2713
2020
Q3
$5.14M Sell
59,202
-1,398
-2% -$120K ﹤0.01% 2887
2020
Q2
$4.91M Buy
60,600
+290
+0.5% +$21.2K ﹤0.01% 2841
2020
Q1
$4.16M Sell
60,310
-18,507
-23% -$1.95M ﹤0.01% 2834
2019
Q4
$9.01M Sell
78,817
-10,821
-12% -$1.35M ﹤0.01% 2648
2019
Q3
$11.7M Sell
89,638
-23,474
-21% -$3.06M ﹤0.01% 2341
2019
Q2
$13.9M Sell
113,112
-40,827
-27% -$4.69M ﹤0.01% 2208
2019
Q1
$16.2M Buy
153,939
+36,825
+31% +$3.96M ﹤0.01% 2023
2018
Q4
$12M Buy
117,114
+64,065
+121% +$7.11M ﹤0.01% 2120
2018
Q3
$6.29M Buy
53,049
+8,404
+19% +$949K ﹤0.01% 2966
2018
Q2
$4.29M Buy
44,645
+11,756
+36% +$1.09M ﹤0.01% 3299
2018
Q1
$2.67M Buy
32,889
+3,025
+10% +$234K ﹤0.01% 3650
2017
Q4
$2.16M Sell
29,864
-21,220
-42% -$1.45M ﹤0.01% 3884
2017
Q3
$3.14M Buy
51,084
+4,661
+10% +$284K ﹤0.01% 3605
2017
Q2
$2.8M Sell
46,423
-2,593
-5% -$166K ﹤0.01% 3581
2017
Q1
$3.2M Buy
49,016
+12,693
+35% +$900K ﹤0.01% 3457
2016
Q4
$2.55M Buy
36,323
+31,201
+609% +$1.98M ﹤0.01% 3563
2016
Q3
$321K Buy
5,122
+1,161
+29% +$71.6K ﹤0.01% 4909
2016
Q2
$239K Buy
3,961
+1,352
+52% +$74.1K ﹤0.01% 5116
2016
Q1
$130K Sell
2,609
-1,904
-42% -$94.6K ﹤0.01% 5360
2015
Q4
$242K Buy
4,513
+3,566
+377% +$179K ﹤0.01% 5264
2015
Q3
$42K Sell
947
-1,796
-65% -$89.5K ﹤0.01% 6015
2015
Q2
$150K Buy
2,743
+2,446
+824% +$121K ﹤0.01% 5390
2015
Q1
$14K Sell
297
-344
-54% -$14.6K ﹤0.01% 6190
2014
Q4
$26K Sell
641
-162
-20% -$6.38K ﹤0.01% 6682
2014
Q3
$29K Sell
803
-803
-50% -$28.4K ﹤0.01% 6847
2014
Q2
$55K Sell
1,606
-908
-36% -$29.3K ﹤0.01% 6589
2014
Q1
$87K Sell
2,514
-552
-18% -$18.3K ﹤0.01% 6089
2013
Q4
$108K Buy
3,066
+1,878
+158% +$61.5K ﹤0.01% 6070
2013
Q3
$37K Sell
1,188
-4,137
-78% -$122K ﹤0.01% 6584
2013
Q2
$147K Buy
+5,325
New +$141K ﹤0.01% 5893

Other funds holding USPH

Bank of America's USPH Position: Q1 2026 in Review

Bank of America increased its US Physical Therapy (USPH) stake by 11% in Q1 2026, buying an estimated $4.48M and bringing the position to 554,621 shares worth $41.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1732.

Bank of America first reported a position in USPH in Q2 2013 and has held it in 52 quarters since. 229 funds tracked by Wall St. Rank hold USPH as of Q1 2026.

  • Bank of America held 554,621 shares of US Physical Therapy worth $41.6M as of Q1 2026.
  • Bank of America bought 54,656 US Physical Therapy shares in Q1 2026, an estimated $4.48M.
  • US Physical Therapy made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1732 holding.
  • Bank of America first reported a position in US Physical Therapy in Q2 2013 and has held it in 52 quarters since.
  • 229 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.